Abbott Laboratories beat expectations of first quarter earnings .
The healthcare company reported adjusted earnings of 63 cents per share for the first quarter, which exceeded analysts’ estimates of 61 cents per share (based on FactSet survey). Its revenue came in at $7.5 billion, compared to analysts’ expectation of $7.48 billion.
For the second quarter, Abbott has forecasted earnings to range between 79 cents and 81 cents per share, in line with analysts' expectations of 80 cents.
For the full year, the company expects earnings of $3.15 to $3.25 per share, which is also in line with Wall Street's $3.21 expectation.